Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer
NCT05761977
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
Sponsor
Hellenic Cooperative Oncology Group